HER2DX Could Aid Chemotherapy Decision-Making in HER2+ Early-Stage Breast Cancer Read More » November 6, 2025
Adjuvant Durvalumab Plus Tremelimumab Yields DFS Advantage in Resected RCC Read More » November 6, 2025
Comprehensive Molecular Profiling of Renal Medullary Carcinoma Identifies TROP2 As a Promising Therapeutic Target Read More » November 6, 2025
Pancreatic cancer trials fuels hope for new drug fast-tracked by the FDA Read More » November 6, 2025
Atebimetinib Plus Chemo Makes Case As Potential Frontline Option in Pancreatic Cancer Read More » October 16, 2025
FDA Grants Fast Track Status to NG-350A for pMMR Locally Advanced Rectal Cancer Read More » October 16, 2025
Tucatinib Plus Trastuzumab and Pertuzumab Maintenance Improves PFS in HER2+ Metastatic Breast Cancer Read More » October 16, 2025
